Statements (54)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:letrozole
|
| gptkbp:affects |
soft tissues
|
| gptkbp:associated_with |
S S18-SSX fusion gene
|
| gptkbp:caused_by |
genetic mutations
|
| gptkbp:clinical_trial |
ongoing
completed phase I phase II phase III |
| gptkbp:color |
gptkb:yellow
|
| gptkbp:end_of_life |
5-year survival rate
10-year survival rate |
| gptkbp:first_described_by |
1960s
|
| https://www.w3.org/2000/01/rdf-schema#label |
synovial sarcoma
|
| gptkbp:is_involved_in |
cancer support groups
sarcoma support groups |
| gptkbp:is_often_used_in |
young adults
|
| gptkbp:location |
trunk
limbs |
| gptkbp:notable_event |
notable individuals diagnosed
|
| gptkbp:number_of_stages |
localized
recurrent metastatic |
| gptkbp:occurs_in |
1-3 per million
|
| gptkbp:photography |
gptkb:musician
gptkb:MRI CT scan PET scan |
| gptkbp:public_awareness |
Sarcoma Awareness Month
|
| gptkbp:research_focus |
gptkb:vaccine
molecular biology targeted therapy |
| gptkbp:risk_factor |
genetic predisposition
exposure to radiation |
| gptkbp:social_responsibility |
gptkb:healthcare_organization
gptkb:fibrosarcoma gptkb:malignant_peripheral_nerve_sheath_tumor variable biopsy |
| gptkbp:symptoms |
fatigue
weight loss fever pain swelling limited range of motion |
| gptkbp:treatment |
gptkb:hospital
radiation therapy chemotherapy recurrence possible metastasis possible |
| gptkbp:type_of |
biphasic synovial sarcoma
monophasic synovial sarcoma |